Omnicell, Inc. (OMCL) — 8-K Filings

8-K Filings (23)

• 8-K Filing — Apr 28, 2026
• Omnicell Files 8-K for Regulatory Disclosure — Dec 8, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on December 8, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specifi
• Omnicell, Inc. Files 8-K on Financials — Oct 30, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on October 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and ex
• Omnicell, Inc. Files 8-K with Bylaw Amendments and Financials — Oct 6, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on October 6, 2025, reporting events as of September 30, 2025. The filing primarily concerns amendments to its Articles of Incorpora
• Omnicell Files 8-K on Executive Changes and Financials — Aug 25, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on August 25, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certa
• Omnicell Files 8-K on Financials — Jul 31, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on July 31, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhib
• Omnicell Files 8-K on Executive Changes & Financials — Jun 5, 2025 Risk: medium
  Omnicell, Inc. filed an 8-K on June 5, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain
• Omnicell Reports Director/Officer Changes and Shareholder Votes — May 23, 2025 Risk: medium
  Omnicell, Inc. filed an 8-K on May 23, 2025, reporting on events that occurred on May 21, 2025. The filing covers the departure of directors or certain officers
• Omnicell, Inc. Files 8-K Report — May 22, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on May 22, 2025, reporting under Regulation FD and including financial statements and exhibits. The filing details the company's pri
• Omnicell, Inc. Files 8-K on Financials — May 6, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on May 6, 2025, reporting on its results of operations and financial condition, and providing financial statements and exhibits. The
• Omnicell Director Departs, New Director Appointed — Mar 12, 2025 Risk: low
  Omnicell, Inc. announced on March 12, 2025, the departure of director Dr. Robert L. Johnson and the appointment of Dr. David L. Schlotterbeck as a new director.
• Omnicell Announces Director Changes and Compensation Details — Mar 4, 2025 Risk: low
  Omnicell, Inc. filed an 8-K on March 4, 2025, reporting the departure of Director Dr. Robert L. Johnson and the election of new Director Dr. David L. Schlotterb
• Omnicell, Inc. Files 8-K on Financials — Feb 6, 2025 Risk: low
  On February 6, 2025, Omnicell, Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes financial statements an
• Omnicell Secures $500M Credit Facility — Nov 25, 2024 Risk: low
  On November 19, 2024, Omnicell, Inc. entered into a Material Definitive Agreement, specifically a Credit Agreement with Bank of America, N.A. as administrative
• Omnicell, Inc. Files 8-K: Material Agreement, Other Events — Nov 18, 2024 Risk: medium
  On November 18, 2024, Omnicell, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company also
• Omnicell, Inc. Files 8-K on Financials — Oct 30, 2024 Risk: low
  Omnicell, Inc. filed an 8-K on October 30, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and ex
• Omnicell, Inc. Files 8-K: Board & Compensation Updates — Sep 25, 2024 Risk: low
  Omnicell, Inc. filed an 8-K on September 25, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing also includes
• Omnicell, Inc. Files 8-K on Financials — Aug 1, 2024 Risk: low
  Omnicell, Inc. filed an 8-K on August 1, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
• Omnicell Appoints New Chief Legal Officer — May 24, 2024 Risk: low
  Omnicell, Inc. announced on May 21, 2024, the appointment of Carol J. Burt as Chief Legal Officer and General Counsel, effective May 20, 2024. Burt previously s
• Omnicell, Inc. Files 8-K on Financials and Exit Costs — May 2, 2024 Risk: medium
  Omnicell, Inc. filed an 8-K on April 26, 2024, reporting on its results of operations and financial condition. The filing also details costs associated with exi
• Omnicell Reports Executive Changes and Compensation Arrangements — Feb 29, 2024 Risk: low
  Omnicell, Inc. filed an 8-K on February 29, 2024, reporting an event on February 23, 2024, concerning the departure or election of directors or officers and com
• OMNICELL Files 8-K on Financial Results & Operations — Feb 8, 2024 Risk: low
  OMNICELL, INC. filed an 8-K on February 8, 2024, to report on its 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits.' This
• OMNICELL 8-K Signals Potential Leadership/Comp Changes — Jan 11, 2024
  Omnicell, Inc. filed an 8-K on January 11, 2024, reporting an event that occurred on January 5, 2024. This filing indicates a current report regarding potential

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX